Home
Dr Reddys Laboratories Ltd Board of Directors
Board of Directors at Dr Reddys Laboratories Ltd
Independent Director
Independent Director
Independent Director
Co-Chairman & Managing Directo
Independent Director
Key Highlights
- G V Prasad continues to serve as the Co-Chairman & Managing Directo in 2024, maintaining the same position as in the previous year.
- K Satish Reddy continues to serve as the Executive Chairman in 2024, maintaining the same position as in the previous year.
- Shikha Sanjaya Sharma continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Leo Puri joins the board as Lead Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- K P Krishnan joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Dr Reddys Laboratories Ltd
NSE: DRREDDY
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1151.95 |
20 Feb 2025 | 1170.9 |
19 Feb 2025 | 1164.7 |
18 Feb 2025 | 1197.85 |
17 Feb 2025 | 1199.75 |
14 Feb 2025 | 1195.85 |
13 Feb 2025 | 1223.3 |
12 Feb 2025 | 1215.9 |
11 Feb 2025 | 1211.8 |
10 Feb 2025 | 1220.85 |
Company Fundamentals for Dr Reddys Laboratories Ltd
Market Cap
96,123 Cr
EPS
64.4
P/E Ratio (TTM)
17.9
P/B Ratio (TTM)
3.1
Day’s High
1171.65
Day’s Low
1146.0
DTE
0.2
ROE
17.4
52 Week High
1420.2
52 Week Low
1120.01
ROCE
20.7
Market Price of Dr Reddys Laboratories Ltd
1M
1Y
3Y
5Y
Dr Reddys Laboratories Ltd News Hub
Dr Reddys Laboratories Ltd gains for third straight session
Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707
Read more
21 Aug 24
Dr Reddy's formulations manufacturing units receives EIR from USFDA
Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m
Read more
12 Aug 24
Dr Reddys allots 29,790 equity shares under ESOP
Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu
Read more
07 Aug 24
Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
06 Sept 24
Document
Concalls
Aug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptAug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
Transcript